Crossmark

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

Crossref DOI link: https://doi.org/10.1186/s12885-016-2448-1

Published Online: 2016-07-07

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Darlix, Amélie

Lamy, Pierre-Jean

Lopez-Crapez, Evelyne

Braccini, Antoine Laurent

Firmin, Nelly

Romieu, Gilles

Thezenas, Simon

Jacot, William
Funding

Funding for this research was provided by:

GEFLUC (Groupement des Entreprises Françaises dans la Lutte contre le Cancer) Languedoc-Roussillon

SIRIC Montpellier Cancer (INCa-DGOS-Inserm 6045)
License Information

License valid from 2016-07-07